First New York Securities’s bluebird bio BLUE Stock Holding History

First New York Securities’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-132	Closed	-$289K	–	351
2015 Q2	$289K	Buy	+132	New	+$269K	0.14%	68

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

First New York Securities's BLUE Position: Q3 2015 in Review

First New York Securities sold out of bluebird bio (BLUE) in Q3 2015, closing a stake of 132 shares — an estimated $289K sold.

First New York Securities first reported a position in BLUE in Q2 2015 and held it in 1 quarter. The position peaked at $289K in Q2 2015. 192 funds tracked by Wall St. Rank hold BLUE as of Q3 2015.

First New York Securities reported no remaining bluebird bio position as of Q3 2015 after selling out during the quarter.
First New York Securities sold 132 bluebird bio shares in Q3 2015, an estimated $289K.
First New York Securities first reported a position in bluebird bio in Q2 2015 and held it in 1 quarter.
First New York Securities's bluebird bio position peaked at $289K in Q2 2015.
192 funds tracked by Wall St. Rank held bluebird bio as of Q3 2015.

Based on First New York Securities's 13F filing for Q3 2015, filed 27 Oct 2015.